FEATURED NEWS

• HDA Files Lawsuit to Block New York Opioid Law

  July 6, 2018

  Today, the Healthcare Distribution Alliance (HDA), the national trade association for pharmaceutical distributors, filed suit in the U.S. District Court for the Southern District of New York to block enforcement of New York’s Opioid Stewardship Act. The act imposes an unconstitutional $600 million punitive surcharge on pharmaceutical distributors and manufacturers. It bypasses judicial due process and impedes the industry’s comprehensive efforts to mitigate opioid abuse and misuse.

• Michael A. Conley of Novartis Pharmaceuticals Recognized with 2018 Nexus Award for Lifetime Achievement

  June 12, 2018

  The HDA Research Foundation, the non-profit organization of the Healthcare Distribution Alliance (HDA), recognized Michael A. Conley of Novartis Pharmaceuticals Corporation with the 2018 Nexus Award for Lifetime Achievement at the HDA Business and Leadership Conference in Colorado Springs. The award is made possible through the support of Genentech, A Member of the Roche Group, and Mylan Inc.

• HDA 2018 DIANA Awards Honor Manufacturers for Industry Excellence

  June 12, 2018

  The Healthcare Distribution Alliance (HDA) honored pharmaceutical and consumer product manufacturers with the annual Distribution Industry Awards for Notable Achievements in Healthcare (DIANA). The awards were distributed at the HDA 2018 Business and Leadership Conference in Colorado Springs, Colo.

• Americares Honors Mylan with Power of Partnership Award

  June 11, 2018

  Americares, in partnership with the Healthcare Distribution Alliance (HDA), has presented its annual Power of Partnership Award to Mylan, in recognition of its outstanding commitment to increasing access to healthcare around the world. Mylan is among Americares most dedicated and longstanding supporters, providing pharmaceutical products for the organization’s health programs for people affected by poverty or disaster.

• HDA Supports Senate Proposals on Enhanced ARCOS Data Sharing, Development of Centralized Suspicious Orders Database

  May 22, 2018

  In advance of the Senate Judiciary Committee’s hearing to consider, among others, two Senate bills calling for greater coordination and data sharing among distributors, the Drug Enforcement Administration (DEA), state regulatory agencies and local law enforcement, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued the following statement.